accusing them of releasing incorrect information to lower the value of St. Jude's stock so they could profit through a short-selling scheme. The FDA, in partnership with the Department of Homeland Security, is investigating Muddy Waters' …
Noncash assets also included private stock, life insurance policies and even bags of grain ... Other popular charities included St. Jude Children’s Research Hospital, …
Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical Inc. in a cash-stock deal that aims to strengthen the medical device maker's stake in cardiovascular care. Shares of North Chicago, Illinois-based Abbott plunged, while St.
... said Muddy Waters “intentionally” released false claims against its cardiac devices in order to benefit if St. Jude stock depreciated. After the report was released, the company's stock fell 5% from $81.88 a share to $77.82. Prices have …
St. Jude Medical (NYSE:STJ) is having a bad week. An unconfirmed report about lead wires poking through their insulation on its newer, apparently more resistant ICD lead saw the stock slide 6 percent on Tuesday. An analyst …
Huge Deal in the Healthcare Space: Abbott Buys St. Jude Medical Merger arbitrage In merger arbitrage, an investor generally buys the stock of the company being acquired, short sells the relevant ratio of the acquirer’s stock if …
The stock continues to trade well below its price on Wednesday of around $82 per share. St. Jude called the allegations “false and misleading.” St. Jude in April agreed to sell itself to Abbott, and the deal was widely considered a slam dunk …
MINYANVILLE ORIGINAL Twenty-four hours after Vikram Pandit was unceremoniously squeezed out at Citigroup (C), Indra Nooyi did little to redeem the reputation of Indian CEOs, with PepsiCo (PEP) ending down in an up market after …